Scarica l'app Stockscreener
17.03
0.41%
0.07
Dopo l'orario di chiusura:
17.05
0.02
+0.12%
Panoramica
Notizia
Cronologia dei prezzi
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Crescent Biopharma Inc Borsa (CBIO) Ultime notizie
Enterprise value to EBITDA forward of Crescent Biopharma, Inc. – NASDAQ:CBIO - TradingView
Price to sales forward of Crescent Biopharma, Inc. – FWB:C68 - TradingView
ETFs Investing in Crescent Biopharma, Inc. Stocks - TradingView
Crescent Biopharma Inc (CBIO) - MSN
Crescent Biopharma files prospectus for $500M mixed shelf - scanx.trade
Form S-3 Crescent Biopharma Inc For: 1 July By Investing.com - Investing.com Canada
Crescent BiopharmaMay Offer And Sell Up To $500 Million Of SecuritiesSEC Filing - TradingView
Crescent Biopharma (NASDAQ: CBIO) files $500M shelf; $200M ATM with Jefferies - Stock Titan
Crescent Biopharma, Inc.(NasdaqCM: CBIO) added to Russell 2000 Index - marketscreener.com
Crescent Biopharma Company Profile & Introduction - Moomoo
Crescent Biopharma(CBIO) Stock Options Chain | Quotes & News - Moomoo
Crescent Biopharma: Intriguing Developer Of ADC/PD1-VEGF Assets May Not Be Sufficiently Derisked - Seeking Alpha
Crescent Biopharma, Inc.(NasdaqCM:CBIO) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Crescent Biopharma, Inc.(NasdaqCM: CBIO) added to Russell 2000 Growth Benchmark - marketscreener.com
Crescent Biopharma, Inc.(NasdaqCM: CBIO) added to Russell 3000E Growth Benchmark - marketscreener.com
Crescent Biopharma, Inc.(NasdaqCM: CBIO) added to Russell Microcap Index - marketscreener.com
CBIOCrescent Biopharma Inc Short Interest - Finviz
Crescent Biopharma, Inc. Actuals & Estimates (NASDAQ:CBIO) - TradingView
Crescent Biopharma Announces Grants of Inducement Awards - GlobeNewswire
CBIO Forecast — Price Target — Prediction for 2027 - TradingView
Crescent Biopharma awards 65,100 options to 3 new hires - Stock Titan
Stifel Nicolaus Reaffirms Their Buy Rating on Crescent Biopharma (CBIO) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Sionna Therapeutics, Inc. (SION) and Crescent Biopharma (CBIO) - The Globe and Mail
Crescent Biopharma CFO Scalzo sells $20,004 in shares By Investing.com - Investing.com UK
Crescent Biopharma general counsel sells $21,911 in shares - Investing.com UK
Crescent Biopharma CEO Joshua Brumm sells $761k in shares By Investing.com - Investing.com India
Crescent Biopharma CFO Scalzo sells $20,004 in shares - Investing.com UK
Crescent Biopharma general counsel sells $21,911 in shares By Investing.com - Investing.com South Africa
Form 4 Crescent Biopharma Inc For: 23 June - Investing.com UK
Crescent Biopharma CEO Joshua Brumm sells $761k in shares - Investing.com UK
Form 4 Crescent Biopharma Inc For: 23 June By Investing.com - Investing.com Nigeria
CRESCENT BIOPHARMA (CBIO) CMO auto-sells shares to cover RSU taxes - Stock Titan
Crescent Biopharma (CBIO) CFO sells 1,112 shares to cover RSU taxes - Stock Titan
Tax-related insider share sale at Crescent Biopharma (CBIO) under Rule 10b5-1 - Stock Titan
CRESCENT BIOPHARMA (CBIO) CSO’s 1,288-share sale covers RSU tax withholding - Stock Titan
Crescent Biopharma (CBIO) insider sale covers taxes on RSU vesting - Stock Titan
Crescent BioPharma (CBIO) COO tax-related sale of 20,549 shares - Stock Titan
Crescent Biopharma (CBIO) CEO’s pre-planned tax sale covers RSU vesting - Stock Titan
Stifel reiterates Crescent Biopharma stock rating on rival trial data By Investing.com - Investing.com Australia
Cantor Fitzgerald reiterates Crescent Biopharma stock rating - Investing.com
Cantor Fitzgerald reiterates Crescent Biopharma stock rating By Investing.com - Investing.com Nigeria
Stifel reiterates Crescent Biopharma stock rating on rival trial data - Investing.com
Crescent Biopharma Discloses Executive 10b5-1 Trading Plan Adoptions in Amended Q1 2026 SEC Filing - Minichart
1.17%
2.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):